BlackRock reports 5.3% stake in Kodiak Sciences
Kodiak Sciences Inc reports that BlackRock, Inc. beneficially owned 3,273,386 shares of Common Stock, representing 5.3% of the class as of 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kodiak Sciences Inc reports that BlackRock, Inc. beneficially owned 3,273,386 shares of Common Stock, representing 5.3% of the class as of 03/31/2026. The filing shows BlackRock has sole voting power for 3,221,479 shares and sole dispositive power for 3,273,386 shares. The schedule is signed by a BlackRock managing director on 04/27/2026.
Insights
BlackRock holds a 5.3% stake in Kodiak Sciences as of 03/31/2026.
BlackRock's Schedule 13G lists 3,273,386 shares beneficially owned and reports full dispositive control over those shares, with 3,221,479 shares subject to sole voting power. This identifies BlackRock as a substantial institutional holder.
Because the filing is a Schedule 13G, it reflects a passive investment filing; the filing does not indicate active control or changes to Kodiak's operations. Subsequent filings would show material changes in ownership or voting intent.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
sole dispositive power regulatory
sole voting power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does BlackRock (KOD) report owning?
What type of SEC filing is this for KOD?
What are the important dates in the filing?
Does the filing identify other persons with >5% ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.